Pembrolizumab-Induced Delayed-Onset Hepatitis

Hepatitis is one of the serious immune-related adverse events (irAEs). However, delayed-onset hepatitis induced by immune-checkpoint inhibitors (ICIs) is rare, and the histopathological features remain to be clarified. A 65-year-old woman with advanced lung adenocarcinoma in the right upper lobe (cT...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanaoka, Kensuke, Moriizumi, Kazunori, Okada, Hideyasu, Iwahashi, Kiyoshi, Tsuji, Hiromi, Yasuoka, Hironao, Minami, Seigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670324/
https://www.ncbi.nlm.nih.gov/pubmed/33250701
http://dx.doi.org/10.1159/000509953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670324/
https://www.ncbi.nlm.nih.gov/pubmed/33250701
http://dx.doi.org/10.1159/000509953

Ejemplares similares